Papillomavirus Infection: Clinical Trials

2 trials for Papillomavirus Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Papillomavirus Infection: new trials by email Literature Review of Papillomavirus Infection trials Research Report on Papillomavirus Infection

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine
GSK Biologicals' HPV-16/18 Vaccine (Cervarix™), Havrix™ - Cervical Intraepithelial Neoplasia, Papillomavirus Infection
Phase 3CompletedGlaxoSmithKline12452005-10-012012-09-18
A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)
Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine, Comparator: Placebo - Healthy Adult Female Participants, Prevention
Phase 3CompletedMerck Sharp & Dohme LLC38192004-06-162017-04-21

Narrower conditions

Papillomavirus Infections (2)  ·  Uterine Cervical Dysplasia (1)

Broader conditions

Communicable Diseases (2)  ·  DNA Virus Infections (2)  ·  Disease Attributes (2)  ·  Genital Diseases (2)  ·  Infections (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Sexually Transmitted Diseases (2)  ·  Sexually Transmitted Diseases, Viral (2)  ·  Tumor Virus Infections (2)  ·  Urogenital Diseases (2)  ·  Virus Diseases (2)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases, Female (1)

Interventions

Hepatitis A Vaccines (1)  ·  Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1)  ·  human papillomavirus vaccine, L1 type 16, 18 (1)

Sponsors

GlaxoSmithKline (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

Colombia (1)  ·  Germany (1)  ·  Honduras (1)  ·  Panama (1)  ·  Taiwan (1)

Results publications

PMID 19493565, PMID 19652630, PMID 19935017, PMID 21629249, PMID 22265115, PMID 22518014, PMID 24391768, PMID 29074187, PMID 32184277